[HTML][HTML] Utilização de medicamentos potencialmente inapropriados por idosos em domicílio

LM Lopes, TP Figueiredo, SC Costa… - Ciência & Saúde …, 2016 - SciELO Brasil
O objetivo foi avaliar a frequência de utilização em domicílio de medicamentos
potencialmente inapropriados por idosos e analisar a significância clínica. Trata-se de …

Helicobacter pylori Eradication Treatment in Older Patients

P Jonaitis, J Kupcinskas, JP Gisbert, L Jonaitis - Drugs & Aging, 2024 - Springer
Helicobacter pylori is the main etiopathogenetic factor of chronic gastritis, peptic ulcer
disease and gastric cancer. The world's population is shifting towards older people, who …

[HTML][HTML] Use of potentially inappropriate medications by the elderly at home

LM Lopes, TP Figueiredo, SC Costa… - Ciencia & saude …, 2016 - SciELO Public Health
The goal of this study was to assess how often potentially inappropriate medicines are used
by the elderly at home, and analyze its clinical significance. This is a retrospective cross …

The effect of antiplatelet agents on bleeding-related complications after ureteroscopy

ME Westerman, V Sharma, J Scales… - Journal of …, 2016 - liebertpub.com
Abstract Introduction: The American Urological Association (AUA) guidelines state that
continuing anticoagulation and antiplatelet agents in routine ureteroscopy (URS) is safe and …

Japanese postmarketing surveillance of clopidogrel for patients with non-ST-segment-elevation acute coronary syndrome indicated for percutaneous coronary …

Y Morino, J Ako, M Kobayashi, M Nakamura - Cardiovascular intervention …, 2014 - Springer
Clopidogrel in combination with aspirin has been a standard therapy for patients who have
undergone percutaneous coronary intervention. The present study was conducted as a …

[HTML][HTML] Impact of Age, Multimorbidity and Frailty on the Prescription of Preventive Antiplatelet Therapy in Older Population

C Laborde, J Barben, AM Mihai, V Nuss… - International Journal of …, 2020 - mdpi.com
Platelet aggregation inhibitors (PAI) have widely proven their efficiency for the prevention of
ischemic cardiovascular events. We aimed to describe PAI prescription in an elderly …

Faut-il adapter les médicaments antidiabétiques et cardiovasculaires chez la personne âgée diabétique?

J Doucet, L Bordier, A Marinari, A Proux… - Médecine des maladies …, 2013 - Elsevier
Résumé Cet article précise les spécificités de la prise en charge médicamenteuse du
diabète et des maladies cardiovasculaires chez les diabétiques âgés. Adapter un …

[PDF][PDF] UFR des Sciences de Santé Circonscription Médecine

C LABORDE - 2017 - nuxeo.u-bourgogne.fr
Les maladies cardio-vasculaires (MCV) représentent 45% des causes de décès en Europe,
entrainant plus de 4 millions de morts par an dont 65% surviennent après 65ans (1). L'âge …

All medicines are drugs but not all drugs are medicines: pharmacoepidemiological approaches to assess the use of prescription/OTC medicines, herbs, dietary …

A Loraschi - 2013 - irinsubria.uninsubria.it
My PhD study programme has been focused on pharmacoepidemiologic topics.
Pharmacoepidemiology applies epidemiologic reasoning, methods and knowledge to the …

[引用][C] Etude de la consommation chronique d'inhibiteurs de la pompe à protons en EHPAD: indications documentées et médications associées pour 134 résidents

R Van Overloop - Disponible sur: https://dumas. ccsd. cnrs. fr/dumas …, 2015